Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) closed its last session at $2.77. The stock traded within a range of $2.65 and $2.87. The company operates in the Healthcare sector with a market capitalization of 376080. Trading volume for Idera Pharmaceuticals, Inc. was 3.21 Million in its previous trading session. Currently, Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has an average volume of 978.08 Million.

Company Profile

Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera’s proprietary drug candidates are designed to modulate Toll-like Receptors, the body’s first line of immune defense. Idera’s pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.

Analyst Views

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) received a Buy rating from 1 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) touched its 1-Year High price of $2.87 on 10/11/17 and its 1-Year Low price of $1.30 on 01/31/17.

EPS & Financials

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) reported its EPS in the last quarter as $-0.14/Share lagging the analyst estimate of $-0.11/Share by a difference of $-0.03. This showed a surprise of -27.3% in the last quarter earnings.

For the current quarter, 6 analysts are projecting a mean EPS of $-0.12/share. According to their observations and findings, the stock could provide a high EPS of $-0.1/share and a low EPS of $-0.15/share.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has a 20-Day average volume of 1.23 Million. According to today’s trading volume Idera Pharmaceuticals, Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.

The company currently has an insider ownership of 0.4 Percent and Institutional ownership of 31.6 Percent. The return on assets stands at -55.1%, Return on Equity currently is -61.1% and the Return on Investment value is -37.3%.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 22.04% with a 50-Day Simple Moving Average of 37.24 percent. As of today, the company has a SMA200 (200-day simple moving average) of 46.91 Percent. The Stock has YTD (year to date) performance of 84.67 percent.

The TTM operating margin for the company stands at 0%. The return on invested capital is at -37.3%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 46.91%, and has a solid year to date (YTD) performance of 84.67% which means that the stock is constantly adding to its value from the previous fiscal year end price.